Dicerna Pharma (DRNA) Tops Q3 EPS by 17c

November 7, 2016 4:38 PM EST
Get Alerts DRNA Hot Sheet
Trade DRNA Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment